Transplant News and Research RSS Feed - Transplant News and Research

Loyola University Medical Center recognized as one of nation's Most Wired hospitals

Loyola University Medical Center recognized as one of nation's Most Wired hospitals

For the twelfth time in 14 years, Loyola University Medical Center has been named one of the nation's Most Wired hospitals. [More]
Immune marker predicts infection risk in critically ill children with traumatic injuries

Immune marker predicts infection risk in critically ill children with traumatic injuries

Researchers studying critically ill children with traumatic injuries have identified an immune marker that predicts which patients are likely to develop a hospital-acquired infection. [More]
Fecal transplantation safe, effective for treating C. difficile in immunocompromised patients

Fecal transplantation safe, effective for treating C. difficile in immunocompromised patients

Researchers have found that fecal transplantation is effective and safe for treating C. difficile in immunocompromised patients. This is the result of a study led by Colleen Kelly, M.D., a gastroenterologist in the Center for Women's Gastrointestinal Medicine at The Women's Medicine Collaborative. [More]
Older kidney donors enjoy similar life expectancy as people who did not donate their kidneys

Older kidney donors enjoy similar life expectancy as people who did not donate their kidneys

Previous studies linking older age with kidney and heart disease have raised concerns about the safety of living kidney donation among older adults. [More]
Telemedicine could improve quality of life of patients with chronic liver diseases

Telemedicine could improve quality of life of patients with chronic liver diseases

Although telemedicine could improve the quality of life of patients with chronic liver diseases, viable home care systems are still lacking. Scientists working on the EU-project "d-LIVER" mean to remedy this situation. Initial results have now been released. [More]
Study: Older kidney donors enjoy similar longevity, cardiovascular health as other healthy individuals

Study: Older kidney donors enjoy similar longevity, cardiovascular health as other healthy individuals

Older kidney donors enjoy similar longevity and cardiovascular health as other healthy mature individuals, according to a new study published in the American Journal of Transplantation. [More]
New gene therapy may be effective for fighting fungal infections in cancer patients

New gene therapy may be effective for fighting fungal infections in cancer patients

Sleeping Beauty and fungal infections - not two items one would normally associate together, but for immunocompromised cancer patients they may prove to be a helpful combination. [More]
Analysis of clinical trials reveals urgent need to increase Alzheimer's drug development

Analysis of clinical trials reveals urgent need to increase Alzheimer's drug development

Researchers at the Cleveland Clinic Lou Ruvo Center for Brain Health have conducted the first-ever analysis of clinical trials for Alzheimer's disease (AD), revealing an urgent need to increase the number of agents entering the AD drug development pipeline and progressing successfully towards new therapy treatments. [More]
New study finds link between lower socioeconomic status and higher rates of peripheral artery disease

New study finds link between lower socioeconomic status and higher rates of peripheral artery disease

Previous research has established a link between lower socioeconomic status and an increased risk of cardiovascular disease. In a new study led by Brigham and Women's Hospital, researchers have found that there are also higher rates of peripheral artery disease (PAD) in individuals with low income and lower attained education levels in the United States. [More]
Australian immunologists uncover additional role for antibody-making 'B cells'

Australian immunologists uncover additional role for antibody-making 'B cells'

A discovery by Australian immunologists, uncovering an additional role for antibody-making 'B cells', is considered important enough by the American Association of Immunologists to rank it among the top 10% of articles in the latest issue of The Journal of Immunology, off the press today. [More]
Children who undergo simple emergency surgeries on weekends are more likely to die

Children who undergo simple emergency surgeries on weekends are more likely to die

Children who undergo simple emergency surgeries, such as hernia repairs or appendix removals, on weekends are more likely to suffer complications and even die than children getting the same kind of treatment during the week, according to results of a Johns Hopkins Children's Center study. [More]
Bone marrow transplantation shows promising results among patients with severe sickle cell disease

Bone marrow transplantation shows promising results among patients with severe sickle cell disease

Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA. [More]
Researchers find unique cell type that can protect against uveitis

Researchers find unique cell type that can protect against uveitis

Researchers at the National Eye Institute (NEI) have found a unique cell type that, in tests on mice, can protect against uveitis—a group of inflammatory diseases that affect the eye and can cause vision loss. [More]
Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Cidara Therapeutics closes $32M Series A financing to advance novel echinocandin antifungal drug

Cidara Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it has completed a $32 million Series A financing that will enable it to advance candidates from the company's Cloudbreak™ targeted immunotherapy platform and biafungin™, a novel long acting echinocandin antifungal drug, into human clinical studies. [More]
Novel method triples length of time organs can be preserved for transplantation

Novel method triples length of time organs can be preserved for transplantation

A system developed by investigators at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine allowed successful transplantation of rat livers after preservation for as long as four days, more than tripling the length of time organs currently can be preserved. [More]
Advocacy group publicizes child deaths from accidental shootings

Advocacy group publicizes child deaths from accidental shootings

Almost two children a week were killed in unintentional shootings during the 12 months that followed the shooting at Sandy Hook Elementary School, according to a report by the gun control group Everytown for Gun Safety. [More]
New data analysis technique improves monitoring of kidney patients

New data analysis technique improves monitoring of kidney patients

A new data analysis technique radically improves monitoring of kidney patients, according to a University of Leeds-led study, and could lead to profound changes in the way we understand our health. [More]
Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Janssen seeks expanded approval of VELCADE from EU for Mantle Cell Lymphoma

Janssen-Cilag International NV today announced its submission of a type II variation to the European Medicines Agency to expand the label for VELCADE (bortezomib) to include its use, in combination with rituximab, cyclophosphamide, doxorubicin and prednisone, for the treatment of adult patients with previously untreated Mantle Cell Lymphoma (MCL). [More]
EMA CHMP adopts positive opinion for Bristol-Myers Squibb’s Daklinza for HCV treatment

EMA CHMP adopts positive opinion for Bristol-Myers Squibb’s Daklinza for HCV treatment

Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults. [More]
Cancer drug shows promise in treating blood cell disorders

Cancer drug shows promise in treating blood cell disorders

Scientists working to make gene therapy a reality have solved a major hurdle: how to bypass a blood stem cell's natural defenses and efficiently insert disease-fighting genes into the cell's genome. [More]